1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis program supports researchers pursuing next-generation spatial biology by providing access to Illumina Spatial Technology, an advanced NGS-based workflow with single-cell resolution and whole transcriptome coverage.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Researchers pursuing next-generation spatial biology. Confirm the full requirements in the official notice before applying.
The Signios Bio × Illumina Spatial Transcriptomics Grant Program is funded by Signios Bio and Illumina. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NSF 26-517 replaces the core solicitations of Environmental Biology, Integrative Organismal Systems and Molecular and Cellular Biosciences with a single directorate-wide opportunity. Proposals are accepted anytime, sorted centrally by NSF rather than targeted by the PI, and reorganized under three inquiry areas. Here is what the $280 million actually buys, why the loss of program targeting cuts both ways, and what to do before the September 16 webinar.
Read articleThe Hewlett Foundation's Emerging Technology and Security Initiative commits $20 million a year through 2031 across AI, biotechnology, and quantum computing security. Its 2026 exploratory grants went to thirteen named institutions with no open call. For organizations outside that list, the path in runs through a specific set of moves — and the five-year term starting in 2027 is the window.
Read article